Science-Based IME/CME Value Proposition

CME as a Strategic Asset

AOE helps pharmaceutical CME and IME leaders address challenges and demonstrate value within your organization.  AOE will provide tools and tactics tailored to helping your team demonstrate value to management by establishing the IME/CME team as a strategic asset within the organization.

AOE’s Science-Based IME/CME Value Proposition includes identification of CME stakeholders within your organization, determination of clinical priorities within therapeutic funding areas, as well as analysis of available educational outcomes data.  Our methodology delivers resources that can be used to:

• Illustrate the value of CME support
• Align compliance and business goals within the organization
• Integrate the IME/CME team as part of decision-making stakeholder group
• Establish an on-going commitment to CME